Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n°159

Posts Tagged ‘research’

New Absolute Research Reveals That Endpoint Security Tools Fail, Reliably and Predictably

Posted by fidest press agency su venerdì, 19 aprile 2019

Absolute (TSX: ABT), the leader in endpoint resilience, today revealed that endpoint security tools and agents fail, reliably and predictably, based on findings from its new 2019 Global Endpoint Security Trends Report. From there, every additional security tool only amplifies complexity and increases the probability of failure and decay, in turn, exposing the dangers of equating IT security spending with security and risk maturity. The study analyzed data from six million devices and one billion change events over the course of a year.The endpoint has quickly become valuable real estate for security tools and controls, as traditional network perimeters have given way to cloud-based models in support of the digital workforce. Global security spending is forecast to reach $128 billion by 2020 with endpoint security spend comprising 24 percent of that total(1), and yet, over 70 percent of breaches originate on the endpoint. The complexity of endpoint device controls creates a false sense of security among organizations while, in reality, causing security gaps and significant risks due to regular and reliable tool failure. Staggering findings on endpoint security degradation include:
42 percent of all endpoints are unprotected at any given time. Two percent of endpoint agents fail per week, meaning 100 percent of endpoint security tools eventually fail – no tool is immune28 percent of all endpoints are unprotected by anti-malware with 21 percent of these endpoints unprotected due to outdated or broken agents and 7 percent due to missing agents 100 percent of devices will have failed encryption controls at least once within one year. Almost 1 in 5 devices become unreachable due to client management tool failures Client patch management agents fail around 50 percent more often than encryption agents As cybercrime threatens to cost the world $6 billion annually in damages by 2021, organizations need to address these issues. IT and security teams must be able to better understand what is happening on their devices and respond to suspicious events to reduce security failures. Organizations should analyze the tools already in use to identify blind spots or opportunities to strengthen their defenses before adding more security controls.
The “2019 Endpoint Security Trends” report analyzes data compiled over the course of a year by Absolute’s security research team. The devices represent data from 12,000 anonymized organizations across North America and Europe, and a third-party research organization was commissioned to conduct in-depth, exploratory interviews with senior executives from Fortune 500 companies to offer context to the findings.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Company Profile for ABI Research

Posted by fidest press agency su sabato, 23 marzo 2019

ABI Research provides strategic guidance for visionaries needing market foresight on the most compelling transformative technologies, which reshape workforces, identify holes in a market, create new business models and drive new revenue streams. ABI’s own research visionaries take stances early on those technologies, publishing groundbreaking studies often years ahead of other technology advisory firms. ABI analysts deliver their conclusions and recommendations in easily and quickly absorbed formats to ensure proper context. Our analysts strategically guide visionaries to take action now and inspire their business to realize a bigger picture. For more information about subscribing to ABI’s Research Services as well as Industrial and Custom Solutions, visionaries can contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit http://www.abiresearch.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

“Research Report on Paper and Paperboard Import in China, 2019-2023”

Posted by fidest press agency su lunedì, 18 marzo 2019

Based on this research, the demand for paper and paperboard imports in China will continue to grow from 2019 to 2023.The major driving forces include the lower average price of imports than domestic counterparts and the sluggish growth in domestic production of paper and paperboard resulting from the shortage of raw materials and the upward costs of labor, land, energy resources and other production factors.
According to this analysis, with the development of China’s economy and the improvement of living standards, the per capita consumption of paper and paperboard shows an upward trend. Meanwhile, China’s net annual population growth is between 8 million and 10 million, which leads to an increasing demand for paper and paperboard in China and promotes the development of China’s papermaking industry.However, the papermaking industry is dependent on forest resources which are scarce in China. As China tightens its environmental protection policies and the forest coverage rate decreases, the fiber materials for papermaking are in increasingly short supply. Besides, the labor costs in the Chinese manufacturing sector keeps rising. Therefore, China needs to import a large quantity of paper and paperboard to cover the shortage of domestic capacity.
The Chinese government has set no administrative barriers against paper and paperboard import, e.g. making paper and paperboard exclusive to state-owned enterprises, or introducing import quota administration for paper and paperboard. But import tariffs vary greatly among China’s paper and paperboard imports. For instance, the MFN rate and general rate on the commodity that has the heaviest tax burden is respectively 35% and 100%. The import tariffs on newsprint, kraft paper, etc. are lower with the lowest MFN rate being 2%.
According to this analysis, the import volume of paper and paperboard in China is rising in recent years. It reached 6.27 million tons in 2018, increasing by 122.3% as compared to 2014. And the import value reached USD 5.53 billion, increasing by 54% as compared to 2014.
The reasons for the growing paper and paperboard imports mainly include: (1) The price of imported paper and paperboard is lower than that of domestic counterparts; and (2) the quality of imported paper and paperboard is better than that of domestic counterparts. But market trends vary greatly among China’s paper and paperboard imports.Overall, product segments that have great price differences with domestic counterpart see faster growth. For example, with the development of Intermedia, the sales volume of newspaper, magazines and other print media is decreasing in China, which brings down the demand for newsprint. However, the import volume of newsprint in China grew by 860% from 2014 to 2018 because the price of imported newsprint was far lower than that of domestic newsprint.In recent years, the demand for liner board keeps rising with the rapid development of the e-commerce and logistics industries. As the import price differed little from the domestic market price, the import volume of liner board in China grew by only 65.10% from 2013 to 2017.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Cutting-Edge Option Care Research Presented at NHIA Finds Home IV Antibiotic Method Can Affect Adherence, Cost

Posted by fidest press agency su sabato, 16 marzo 2019

New research by Option Care Enterprises, Inc. (“Option Care”), the nation’s leading provider of home and alternate site infusion therapy services, suggests the method of antibiotic intravenous (IV) administration can improve patient compliance while decreasing costs. The study1 was presented today at the National Home Infusion Association (NHIA) Annual Conference and is a finalist for the “Outstanding Abstract Achievement Award.”
The researchers analyzed patient compliance by comparing four techniques for antibiotic self-administration and determined ease of providing therapy was a significant factor. They concluded patients were significantly more likely to comply with therapy if they used the elastomeric pump or IV push than if they used the gravity/mini bag or electronic pump. Additionally, in many cases IV push and elastomeric pump are less costly.“There’s a common perception that the gravity/mini bag is the least expensive method, but our research shows not only are IV push and elastomeric pump often more cost-effective, but patients find them easier to use, decreasing the likelihood that they will skip doses, which can lead to failed therapy and hospital readmission,” said Julie Wurdeman, PharmD, an Option Care infusion pharmacist and primary author of the study. “Our findings have implications for helping establish the most appropriate method of administration and underscore the value of collaboration among patients and the care team.”
The type of IV antibiotic therapy typically is chosen by the pharmacist in collaboration with the physician and determined by several factors including the medication, frequency of therapy (typically one to three times a day), rate of infusion as well as provider preference, patient lifestyle and age. The research suggests that patient compliance and cost should be factored into the equation.Researchers studied treatment compliance in 688 Option Care home infusion patients who were treated between October 2017 and October 2018 and who missed one or more doses of IV antibiotics. They found the percentage of doses missed by technique was: 2.6 percent elastomeric pump, 2.7 percent IV push, 5 percent mini bag and 8.6 percent electronic pump.There is a wide variation between methods in the cost of administration (factoring in equipment, compounding and patient education, but not medication), including a 209 percent difference between the least-expensive, IV push, and the most-expensive, electronic pump. The cost varies depending on the number of times per day and the rate at which the antibiotic is provided, as well as whether equipment can be reused and other factors.In home antibiotic therapy, the patient infuses the medication through a catheter (placed by a nurse in a vein, usually in the hand or arm).

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

KBRA Releases Research on Auto Loan Extensions

Posted by fidest press agency su mercoledì, 27 febbraio 2019

Kroll Bond Rating Agency (KBRA) releases a research report examining the use of subprime auto loan extensions as a loss mitigation tool for ABS servicers. In general, KBRA believes the use of extensions ultimately benefits ABS investors by reducing delinquency and default rates. However, a high rate of extensions within a securitized collateral pool can meaningfully increase bond duration and expose ABS investors—particularly owners of deeply subordinated tranches—to tail risks. As such, it is important for investors to understand each servicer’s policy regarding extensions, as well as how extensions are handled within ABS deal structures.
KBRA is a full service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO. In addition, KBRA is designated as a designated rating organization by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus, is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider, and is a certified Credit Rating Agency (CRA) by the European Securities and Markets Authority (ESMA). Kroll Bond Rating Agency Europe Limited is registered with ESMA as a CRA.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Research in Otolaryngology (ARO) Conference

Posted by fidest press agency su venerdì, 8 febbraio 2019

Decibel Therapeutics will showcase capabilities across its inner ear-focused drug discovery and development platform at the 42nd annual mid-winter meeting of the Association for Research in Otolaryngology (ARO) from February 9-13, 2019. The data to be presented will demonstrate new insights on the delivery of medicines to the inner ear through multiple modalities, including gene therapy and biologics, as well as the development of biomarkers, assays and tools to address cochlear synaptopathy and other disorders.“This last year has been transformative for Decibel,” said Michael Su, Ph.D., Decibel’s chief scientific officer. “Not only have we advanced two compounds for the prevention of hearing loss into Phase I clinical studies, but we’ve also strengthened our discovery and delivery capabilities in support of our early stage pipeline programs in monogenic hearing loss, tinnitus and balance. We’re looking forward to sharing this broader suite of capabilities with our colleagues at ARO.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

“Research Report on Timber Import in China, 2019-2023”

Posted by fidest press agency su giovedì, 24 gennaio 2019

According to the report, in 2017, Russia, the U.S., New Zealand and Canada, the four largest sources of China’s timber imports, provided 64% of the total import volume of timber in China. In particular, Russia and the U.S. provided about 31% and nearly 10% respectively of the total timber imports.On August 3, 2018, China’s Ministry of Commerce announced a 5% to 25% tariff increase on U.S. exports worth USD 60 billion, including a 25% tariff increase on U.S. timber. Evidently, the Sino-U.S. trade war will have a certain impact on China’s timber import.
The domestic supply of merchantable timber has been contracting, and China’s reliance on timber imports has exceeded 50% since the Chinese government announced the prohibition on the commercial cutting of natural forests in 2017. It is expected that the international timber prices will show an upward trend in the next few years as the import volume of timber keeps rising in China.Some Chinese enterprises have begun to invest in the forestry industry in other countries, mainly Russia, to ensure a stable and adequate supply of timber. By the end of 2018, more than 100 Chinese enterprises had invested in Russia’s forestry industry with a total of over USD 2 billion – and the figures are expected to grow further.The Chinese government has few restrictions on timber import. Therefore, the Chinese market will provide global forestry enterprises with numerous opportunities in the next few years.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Elligo Health Research Acquires Protenium Clinical Research

Posted by fidest press agency su venerdì, 11 gennaio 2019

Elligo Health Research, an integrated research organization, has acquired Protenium Clinical Research. Protenium, an established research group led by Robert Strzinek, Ph.D., D.O., conducts pharmaceutical studies in a broad range of therapeutic areas.Dr. Strzinek has more than 15 years of clinical research experience and will now conduct research at his practice in partnership with Elligo. The acquisition brings the number of patients in Elligo’s Research Ready network to more than one million. As part of Elligo’s Goes Direct® approach, these patients will now have access to clinical research as a care option from their own trusted physician.“Joining Elligo’s Dallas–Fort Worth Community of Research will ensure that we continue to provide the best clinical research opportunities to our patients and help us expand research opportunities across the region,” said Dr. Strzinek. “Our partnership allows us to focus on patient care while benefiting from Elligo’s research relationships and operational expertise.”Dr. Strzinek has completed over 150 research studies and authored numerous journal articles covering several areas including endocrinology and women’s health. He and the Elligo team will continue to conduct research and support other community-based health care providers participating in research.“The opportunity to leverage Dr. Strzinek’s highly experienced practice and integrated clinical operation in our Research Ready network and Communities of Research furthers our mission to bring together and empower health organizations and improve clinical trial access and efficiency,” said John Potthoff, Ph.D., CEO at Elligo. “We are delighted to welcome him, and his staff and patients to the Elligo family.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

The “Mining Investment Asia” conference has been added to ResearchAndMarkets.com’s offering

Posted by fidest press agency su giovedì, 10 gennaio 2019

Singapore – March 27-28, 2019. Mining Investment Asia is a strategic mining conference and exhibition for the leaders of the mining, quarrying and construction materials industries, bringing together 350 attendees from 24 countries.Ministers, mining companies, investors and service providers travel from all over Asia, North America, Europe, Middle East and Africa for four days of partnering, networking and business matching.Join us at an invaluable platform to seek new partnerships, new business and new opportunities.
The event delivers the highest level audience in the region, allowing you to speak and network with key buyers and industry leaders under one roof.The speakers are industry leaders and provide new perspectives on key issues disrupting & innovating mining sector, share cutting edge content and insights on the mining landscape.For more information about this conference visit  https://www.researchandmarkets.com/research/zkcbwj/2day_conference?w=4

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

New research reveals 4.8% of the UK population have elevated liver iron

Posted by fidest press agency su lunedì, 24 dicembre 2018

The study, conducted by the University of Westminster and Perspectum Diagnostics, used MRI to non-invasively assess levels of liver iron. The numbers of individuals with abnormal levels for two key risk factors of significant liver disease are considerable and represent potentially 2 million NHS patients. The UK health system is under-prepared for the current liver disease epidemic.Iron overload is traditionally associated with genetic disorders such as hereditary haemochromatosis (HH) or as a results of repeated blood transfusions. However elevated levels of liver iron are now often associated with metabolic diseases including insulin resistance, type 2 diabetes and NAFLD. Elevated liver iron is associated with the development of fibrosis and cirrhosis and thought to be involved in the progression from fibrosis to liver cancer.Diagnostic pathways for liver iron currently rely on simple blood tests, which often miss early stages of iron accumulation, and liver biopsy. However, ferritin levels can be influenced by liver damage and inflammation, and in many cases do not correlate well with liver iron stores. Therefore, the development of robust, widely available and non-invasive techniques for the measurement of liver iron are needed. This study used the quantitative MRI behind LiverMultiScan to safely and painlessly assess liver health.Haemochromatosis UK, the national charity representing patients with iron overload, have recently launched an awareness campaign in the House of Commons, and received support from the UK government, the National Consortium of Intelligent Medical Imaging, and GE Healthcare and Perspectum Diagnostics, to improve the availability of MRI scanners with LiverMultiScan and automated image processing to identify NHS patients with iron overload.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

A new report from Navigant Research

Posted by fidest press agency su venerdì, 21 dicembre 2018

It examines the cybersecurity landscape for intelligent buildings and the implications of increased Internet of Things (IoT) connectivity. While smart buildings are centered around the ideas of connectivity and interactivity, new interfaces are dramatically increasing access points, providing gateways to sensitive data, and creating new vulnerabilities for building automation systems. Further, the proliferation of IoT-enabled devices and third-party entities has widened the surface area for attack, compounding the security issue by making threat detection less straightforward and more difficult to remedy. Click to tweet: According to a new report from @NavigantRSRCH, this nascent IoT cybersecurity market is expected to show steady growth as the demand for strong security solutions continues to increase.“Cybersecurity issues are expected to grow in tandem with the digital transformation of real estate through intelligent building technologies,” says Casey Talon, research director with Navigant Research. “The information/operational technology (IT/OT) convergence is a necessity for successful deployment and the use of intelligent building solutions, but in many customer organizations, these business units act in isolation. This creates gaps in human capital skill sets, resulting in infrastructure and processes that can be vulnerable to cybersecurity breaches.”Navigant Research recommends intelligent building stakeholders take a proactive approach to cybersecurity threats by determining vulnerabilities and attack vectors and educating the enterprise. Stakeholders should take a layered approach to cybersecurity, in addition to building a cyber threat alliance and continuing to strengthen their line of defense. The report, Cybersecurity Will Define Market Leaders in the Intelligent Buildings Market, examines the cybersecurity landscape for intelligent buildings and the implications of increased IoT connectivity. It analyzes several best practices and strategies that managers and vendors are taking to secure intelligent building systems. The report also provides a list of recommendations for stakeholders to integrate into their cybersecurity frameworks as they continue to build resilience against threat vectors. An Executive Summary of the report is available for free download on the Navigant Research website.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Research Collaboration to Investigate Markers of Immuno-Oncology Response and Resistance

Posted by fidest press agency su giovedì, 20 dicembre 2018

Bristol-Myers Squibb Company (NYSE:BMY), and Boston Medical Center, a private, not-for-profit, academic medical center, today announced a multi-year joint research study to identify and analyze potential sensitivity and resistance markers in patients treated with standard-of-care checkpoint inhibitors. The comprehensive, multi-dimensional study will place an emphasis on uncovering mechanisms associated with lack of response to Immuno-Oncology (I-O) therapies, with the ultimate goal of identifying prognostic and potentially predictive I-O biomarkers in a variety of cancers.“Our newly opened R&D site in Kendall Square is focused on better understanding, and ultimately overcoming, the challenge of I-O resistance. We are thrilled to establish our first partnership since the site opened with our new neighbor, Boston Medical Center, with the goal of uncovering new insights into the biology of cancer and how it evolves with exposure to I-O intervention,” said Saurabh Saha, M.D., Ph.D., senior vice president and global head of translational medicine, Bristol-Myers Squibb. “The information we glean from this collaboration will ultimately inform the development of novel therapeutic strategies to improve response rates and outcomes for patients.” Through the study, researchers will explore the role of tissue and circulating biomarkers on treatment sensitivity and resistance. In addition, scientists will investigate the role of the microbiome as a potential predictive biomarker in patients receiving treatment with immune checkpoint inhibitors.“Boston Medical Center serves a diverse patient population, with 70 percent of our patients coming from underserved communities,” said Matthew Kulke, M.D., chief of hematology/oncology at Boston Medical Center. “These patients are sorely underrepresented in current research studies. We look forward to partnering with Bristol-Myers Squibb on this study to identify and assess biomarkers across a diverse patient population, providing us with a deeper and more comprehensive understanding of I-O resistance.” The two organizations will jointly conduct the research throughout the duration of the study, after which Bristol-Myers Squibb and Boston Medical Center may collaborate to publish results.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Convegno “EU Research and Innovation in our daily life”

Posted by fidest press agency su domenica, 2 dicembre 2018

In Europa si registra il 25% del totale dei casi del cancro diagnosticati nel mondo, una percentuale molto elevata se si considera che nel Vecchio continente vive solo il 9% della popolazione mondiale. Ogni anno circa 4 milioni di cittadini europei sono colpiti da tumore. La mortalità per cancro è diminuita nei Paesi occidentali negli ultimi 25 anni (per quasi tutte le forme neoplastiche), soprattutto nelle donne rispetto agli uomini per la diffusione dei programmi di screening e trattamenti più efficaci. La sopravvivenza netta a 5 e 10 anni è costantemente aumentata negli ultimi anni fino all’80-90% nei tumori della tiroide, della prostata, della mammella e nel melanoma, ma è ancora bassa (circa il 10-20%) nei tumori del cervello, del fegato, del polmone, dell’esofago e del pancreas. È questo il quadro descritto oggi dal prof. Francesco Cognetti, Presidente di Fondazione Insieme Contro il Cancro nella relazione sulle “Nuove frontiere nella lotta contro il cancro” al convegno EU Research and Innovation in our daily life presso il Parlamento Europeo a Bruxelles. “I miglioramenti sono costanti nel tempo – spiega il prof. Cognetti -, ma permangono variazioni tra Paesi europei con differenze nelle cure oncologiche legate a diverse ragioni: l’intensità diagnostica e lo screening che portano a una diagnosi più precoce o tardiva, i trattamenti efficaci, lo stato socioeconomico, lo stile di vita e differenze di salute generale nella popolazione, i costi per i tumori e l’organizzazione delle cure. I dati di sopravvivenza sono migliori in Europa del Nord e centrale e in alcuni Paesi del Sud (Italia e Spagna). Sono invece peggiori nel Regno Unito e in Europa orientale”.
“Per aiutare a ridurre le differenze di sopravvivenza e migliorare le cure oncologiche – osserva il prof. Cognetti -, tutti i Paesi europei dovrebbero perseguire la riduzione della frammentazione dei servizi di cura, promuovere centri multidisciplinari comprensivi di cure oncologiche, una migliore organizzazione e finanziamento del sistema sanitario, la promozione e il finanziamento della ricerca e l’alleanza dell’intera comunità contro il cancro. L’intensa collaborazione tra comunità scientifica, medica, tecnologica e farmaceutica è quindi indispensabile”.

Posted in Estero/world news, Politica/Politics | Contrassegnato da tag: , , | Leave a Comment »

EU Research and Innovation in our daily life

Posted by fidest press agency su sabato, 24 novembre 2018

Bruxelles i terrà il 27 novembre 2018 a Bruxelles, presso la sede del Parlamento Europeo, la Conferenza congiunta di Parlamento europeo e Commissione europea EU Research and Innovation in our daily life, che riunirà ricercatori, politici, rappresentanti delle istituzioni e dell’industria e vedrà la presenza di personalità come Antonio Tajani, Presidente del Parlamento europeo, Carlos Moedas, Commissario europeo per la Ricerca, la Scienza e l’Innovazione e Jean-Pierre Bourguignon, Presidente del Consiglio europeo della Ricerca.
L’incontro intende stimolare gli investimenti nella ricerca, dando uno sguardo ad alcuni tra i maggiori traguardi che l’Unione Europea ha raggiunto in tema di ricerca e innovazione e che sono il risultato di un continuo dialogo tra le istituzioni europee, gli stati membri, le loro università e i centri di ricerca più importanti.A rappresentare la ricerca italiana di eccellenza il professor Luigi Naldini e il professor Alessandro Aiuti, direttore e vice direttore dell’Istituto San Raffaele-Telethon per la Terapia Genica (SR-Tiget), che presenteranno, attraverso il racconto dei genitori, la storia di Margaux, una bambina belga affetta da ADA-SCID, rara malattia genetica che compromette gravemente il sistema immunitario, e curata con successo grazie alla terapia genica sviluppata presso il SR-Tiget di Milano.Margaux oggi ha 5 anni ed è una dei 31 piccoli pazienti affetti da ADA-SCID trattati ad oggi con la terapia genica sviluppata dall’Istituto San Raffaele-Telethon, dal 2016 è divenuta un farmaco e la prima terapia genica con cellule staminali ematopoietiche a essere disponibile sul mercato.

Posted in Estero/world news, Politica/Politics | Contrassegnato da tag: , , , | Leave a Comment »

Research Studies Presented at the 2018 AASLD Liver Meeting Cite Value of Non-invasive Screening for Fatty Liver Disease

Posted by fidest press agency su giovedì, 8 novembre 2018

Researchers will present over 160 peer reviewed posters and oral presentations that include FibroScan during The Liver Meeting, sponsored by the American Association for the Study of Liver Diseases (AASLD), November 9–13, 2018, San Francisco, CA. Echosens, an innovative high-technology company offering the FibroScan family of products, will also share findings of its own research studies on the role of non-invasive screening methods to detect liver disease in these often asymptomatic patients. “FibroScan is the most widely studied tool for quantitative liver assessment in the world, with over 2,000 peer-reviewed research publications,” says Dr. Laurent Sandrin, co-founder of Echosens. “FibroScan brings healthcare practitioners an unprecedented ability to quickly, painlessly and non-invasively assess liver health.” Over 1,000 FibroScan systems have been placed in the United States, and Dr. Sandrin expects that FibroScan could eventually become an important component of point-of-care protocols in the doctor’s office or other healthcare setting, performed as part of an annual exam, during endoscopic screening or other diagnostic testing. With increased adoption by physicians, who recognize that NAFLD is reversible if caught in the early stages and, accompanied by lifestyle changes, FibroScan can emerge as a leading technology in the fight against the looming NAFLD epidemic. “As many as half of adults in the United States may have NAFLD,” continues Dr. Sandrin. “Fibroscan can help detect the disease before it progresses and becomes symptomatic, reducing the risk that patients will develop more serious conditions like fibrosis, cirrhosis, and even cancer of the liver.” As an example, an interim look at an ongoing study of 10,000 patients with no history of liver disease was conducted in community-based endoscopy centers. Using FibroScan, only 43 percent of patients evaluated had what is considered normal livers, while the remainder had some form of liver abnormality, ranging from elevated liver fat to liver fibrosis. This analysis of the first 367 patients suggests a significant rate of undiagnosed steatohepatitis liver disease in the population studied. This high prevalence of disease, a dramatic rise from observations made in previous years, were indicative of the critical need for ongoing assessment.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Navigant Research Report Examines How Cities Can Utilize Smart Highway Technology

Posted by fidest press agency su sabato, 15 settembre 2018

A new report from Navigant Research examines the current state of smart highway technologies, providing an overview of current and recent test installations, and detailing the influence of automated vehicles and electric vehicles (AVs and EVs).Transportation planning is essential for any city, and the evolution of the smart highway is expected to improve road access and safety for the commuters and vehicles that use it. AVs and EVs are key to achieving these benefits, and updated highway infrastructure is a powerful enabler. Click to tweet: A new report from @NavigantRSRCH examines how cities can utilize new smart highway technology.“Smart highways are a significant element of the smart cities industry,” says Ryan Citron, senior research analyst with Navigant. “Sensors and connectivity, road markings and signs, and electric roads are expected to enable smart highways that deliver reduced congestion, fewer collisions, and cleaner air.” According to the report, smart highway concepts in road marking and signage make it easier for machine vision and other sensors to monitor the local road situation, and new highway sensors can send data reports on road conditions to central service centers that then develop and deliver instructions to the fleet to optimize traffic flow. Navigant Research recommends cities engage in long-term road infrastructure planning, while suppliers and technology developers focus on a modular approach and interoperability, and road construction companies collaborate with their suppliers to develop global solutions.This report, The Convergence of Smart Highways and Smart Cities, examines the current state of smart highway technologies. It provides an overview of some current and recent test installations and examines the influence of AVs and EVs. The study also examines various benefits that will result from the successful implementation of smart highways. Recommendations are provided to road construction firms and suppliers on how to take advantage of the market potential and to government agencies on planning for the future.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Research Affiliates’ Partner Mike Aked Relocates to Australia to Support and Grow Firm’s Local Presence

Posted by fidest press agency su sabato, 4 agosto 2018

Research Affiliates, LLC, announces today that Mike Aked, CFA, Partner and Director of Research for Australia, has relocated to Melbourne, where he will support the firm’s network of Australian partners and identify new growth opportunities. He will also be involved with strategic initiatives and research around asset allocation for the firm as well as other research initiatives in support of the Australian market.
Founded in 2002 by Rob Arnott and based in Newport Beach, California, Research Affiliates is a global leader in asset allocation, smart beta, and active equity strategies. Through various Australian distribution partners and direct clients, Research Affiliates’ strategies such as the RAFI™ Fundamental Index™ have been available in Australia for 10 years. Of the A$265 billion* in assets managed globally using RA investment strategies, over A$20 billion is in Australia, making it a significant and important region for the firm.
With Mr. Aked based locally, Research Affiliates hopes to create greater impact via our research insights and tools for Australian investors. This move will also facilitate more frequent in-person dialogue among Research Affiliates and asset owners, local consultants, and distribution partners. “Mike has been an invaluable contributor to Research Affiliates’ growth and success,” explains Katy Sherrerd, President and CEO of Research Affiliates. “He brings with him a deep understanding of markets—particularly on the implementation side—as well as our investment beliefs, research processes, core values, and company culture. Further, his experience working at both superannuation funds and global asset managers makes Mike an excellent representative of Research Affiliates as we strive to deepen our involvement with the Australian investment community.” “Surveying the Australian investment landscape, it is truly a very exciting time to be in my home country. Opportunities to make a meaningful impact abound. I look forward to helping increase our presence and to making sure our research and insights are relevant and impactful to Australian investors,” said Mr. Aked. Mike Aked received a BA with honors in applied mathematics from the University of Sydney, an MS in statistics from the University of Virginia, and an MS in financial mathematics from the University of Chicago. Previously, Mike held positions at Sunsuper, University of Virginia Investment Management Company, and UBS Global Asset Management across four continents. He holds the Chartered Financial Analyst® designation and is a member of both the CFA Society Melbourne and Q-Group Australia.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

2018 Primary Sclerosing Cholangitis Drug Development Pipeline Analysis Report – Research AndMarkets.com

Posted by fidest press agency su sabato, 21 luglio 2018

Primary sclerosing cholangitis (PSC) is a chronic progressive GI disorder that affects the bile volume in the gall bladder. The slowly progressing condition causes inflammation and scaring of bile ducts, which results in improper flow of the digestive liquid.Around 30 companies and universities are focusing on developing treatment options for Primary sclerosing cholangitis.To assist investigators and funding and regulatory organizations, the publisher has come up with a comprehensive report on Primary sclerosing cholangitis pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Primary sclerosing cholangitis pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.In addition to complete details of each product, the report provides key trends in Primary sclerosing cholangitis pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Behavox Accelerates Growth with Opening of Research and Development Center in Montréal this Fall

Posted by fidest press agency su sabato, 21 luglio 2018

Behavox, a pioneering artificial intelligence data analytics firm, announced today they are opening a research and development center in Montréal, Québec, in August, to capitalize on the wealth of talent the city has to offer.When at full capacity, the Montréal office will employ 200 individuals, most of whom will be technology professionals working on Behavox’s industry-leading enterprise data analytics platform, currently used by some of the world’s largest banks, broker-dealers and hedge funds.
Behavox’s machine learning software enables firms to search, interrogate, and generate immediate insights from enormous amounts of employee-generated data, including emails, text messages, trade data and voice calls, all tracked in real-time. “Behavox is first and foremost a machine learning company and we are greatly attracted to the highly diverse technology talent Montréal has to offer,” said Erkin Adylov, Founder and CEO of Behavox. “Montréal is truly an AI development center, with voice and text analytics being particularly strong areas.”The city’s proximity to North American financial centers will help accelerate Behavox’s growth as a leader in behavioural and people analytics, alongside tapping into the soaring Canadian banking market. “This is a very exciting opportunity to expand staffing and R&D capabilities to further serve Behavox’s client base.” Adylov said.
Behavox is a global enterprise headquartered in London, and also has offices in Singapore, New York and San Francisco.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Turnitin and Unizin Partnership Improves Research of Student Writing Performance and Outcomes

Posted by fidest press agency su mercoledì, 11 luglio 2018

A new partnership between Turnitin and Unizin will give college and university instructors better data about how students write and revise their work. Turnitin has been at the forefront of academic integrity and writing solutions for 20 years, and Unizin is a consortium of top U.S. research institutions dedicated to improving access, affordability, and learner success in higher education. Unizin’s Data Platform creates a unified data portrait of students, which makes it easier for faculty to customize instruction and better understand likely student outcomes. Click to tweet.
Retention and graduation rates have been trending downwards at many colleges and universities in recent years. Successful higher education completion is related to students’ ability to meet their courses’ rigorous reading and writing demands. This partnership gives faculty access to improved insights and data around student writing, which allows them to identify areas where students may need support, provide targeted instruction, and ensure institutional academic integrity. A better understanding of student writing progress and performance could help more students successfully graduate.
“At the University of Iowa, we utilize these solutions to make grading easier for faculty and to detect plagiarism,” said Annette Beck, a director in the University of Iowa Office of Teaching, Learning & Technology. “The tools also help students develop their writing skills and understand academic integrity principles, contributing to their success throughout and beyond their academic experience.”
Turnitin Originality Check will generate and send data to the Unizin Data Platform, which consolidates and commonly models many other learning behaviors and data. Unizin universities will leverage Turnitin’s potent data capabilities along with the rich data from this platform to develop research, analytics, and services intended to continuously improve learning outcomes.“With the new Unizin agreement with Turnitin, we will now have access to information about students’ writing process and their reading process through the Unizin Engage platform,” said Anastasia Morrone, Associate Vice President for Learning Technologies at Indiana University. “Having this data in the Unizin Data Platform represents an exciting opportunity to explore how students’ reading and writing contribute to their overall success in college.” “Since its founding, Turnitin has joined forces with higher education institutions to provide advanced digital tools that safeguard academic integrity and promote 21st century skills,” said Turnitin CEO Chris Caren. “Partnering with Unizin allows us to serve even more of the top research institutions in the country and ensures that our upcoming products remain in alignment with the ever-evolving needs of the higher education space.” “We are thrilled to announce this partnership with Turnitin,” said Unizin Executive Director Rob Lowden. “In Turnitin, we have found a vendor who cares about the ecosystem, who sees in Unizin an opportunity to improve teaching and learning in higher education utilizing state of the art technology.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »